DC3 Therapeutics is a full service Contract Research Organization (CRO). We offer a full set of services necessary for drug development. We can support Pre-Clinical and IND Enabling studies. Our team has extensive experience in drug development and the pharmaceutical industry.
DC3 Therapeutics began as a provider of histology services and we've expanded our capabilities to include standard and custom research solutions for biotechnology and clinical stage companies. Our services include histology, in vitro pharmacology and ADME; as well as molecular, cellular, and micro-biology. We are happy to work with our clients to tailor experimentation to their research and development goals and to have them rely on us to deliver quality data. For more complex pre-clinical programs, our expertise allows us to be a single point of contact so our clients can focus on their core business without having to manage multiple CROs. We pride ourselves on our customer service: contact us for consultation on any of your research needs.
DC3 is committed to superior customer service. DC3 understands that drug development is a fast paced and demanding environment. We guarantee that our services will be performed accurately and with a fast turn-around time. To ensure a quick turn around each customer is assigned a secured DC3 account. This account can be used to download data, schedule pickups, and submit questions about data.
DC3 supplies individually wrapped, sterile nasopharyngeal swabs and transport media for sample collection. Available as 50 pack box at 4.00/sample.
DC3 Therapeutics is a CLIA-certified California-licensed Clinical and Public Health Laboratory for the testing of individuals for SARS-CoV-2 (COVID 19). We offer testing for corporate clients and individuals, and can report data in as little as 8 hours using FDA-approved reagents and instrumentation.
MSD (Meso Scale Discovery) is a multi-array (multiplexing) technology for measuring analyte concentrations. The majority of MSD immunoassays are sandwich assays, designed to measure the concentration of specific molecules in complex biological samples. The assays are provided in convenient 96- or 384-well microtiter plates and can be multiplexed for efficient processing.
Meso Scale Discovery
Meso Scale Discovery is a multi-array (multiplexing) technology for measuring analyte concentrations. The majority of MSD immunoassays are sandwich assays, designed to measure the concentration of specific molecules in complex biological samples. The assays are provided in convenient 96- or 384-well microtiter plates and can be multiplexed for efficient processing.
96 well or 384-well runs. Cost listed is for 96-well plate run
Next generation sequencing on the Ion Torrent S5XL
Immunoassays based on Luminex xMAP (multi-analyte profiling) technology enable simultaneous detection and quantitation of multiple secreted proteins (cytokines, chemokines, growth factors, etc.).
RNA isolation from cells in culture or tissue
cDNA synthesis from isolated RNA for qRT-PCR
Label-free Biophysical Characterization
Kinetic binding data and analysis
**Sample requirements: **
0.5-500 ng of material, 10-75uL of sample, 1-200 kDA
11-log dynamic range starting at 100 fM
Assays run on AGILE R100 by Nanomedical Diagnostics
ADME/DMPK Studies Services
Clinical Molecular Diagnostics Services
Lead Identification and Validation Services
DNA Synthesis and Probe Development Services
Human Biospecimen Management and Storage Services
Protein Expression Visualization Services
Antimicrobial Activity Testing Services
Recombinant Protein Expression Services
Clinical Microbiology, Virology and Parasitology Services
"This is a quality collaboration for DNA extraction services. Responses to inquires are fast. The data is consistent and of high quality. And the TAT is efficient and reliable. There is great communication and my contacts are wonderful to work with."
"Great experience and service"
DC3 Therapeutics, LLC has not received any endorsements.